344 related articles for article (PubMed ID: 36982560)
1. Overview of BPH: Symptom Relief with Dietary Polyphenols, Vitamins and Phytochemicals by Nutraceutical Supplements with Implications to the Prostate Microbiome.
Stewart KL; Lephart ED
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982560
[TBL] [Abstract][Full Text] [Related]
2. Nutraceutical treatment and prevention of benign prostatic hyperplasia and prostate cancer.
Cicero AFG; Allkanjari O; Busetto GM; Cai T; Larganà G; Magri V; Perletti G; Robustelli Della Cuna FS; Russo GI; Stamatiou K; Trinchieri A; Vitalone A
Arch Ital Urol Androl; 2019 Oct; 91(3):. PubMed ID: 31577095
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the therapeutic effect against benign prostatic hyperplasia and the active constituents from Epilobium angustifolium L.
Deng L; Zong W; Tao X; Liu S; Feng Z; Lin Y; Liao Z; Chen M
J Ethnopharmacol; 2019 Mar; 232():1-10. PubMed ID: 30529422
[TBL] [Abstract][Full Text] [Related]
4. Phytotherapy for benign prostatic hyperplasia.
Wilt TJ; Ishani A; Rutks I; MacDonald R
Public Health Nutr; 2000 Dec; 3(4A):459-72. PubMed ID: 11276294
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Murraya koenigii- and Tribulus terrestris-based oral formulation versus tamsulosin in the treatment of benign prostatic hyperplasia in men aged >50 years: a double-blind, double-dummy, randomized controlled trial.
Sengupta G; Hazra A; Kundu A; Ghosh A
Clin Ther; 2011 Dec; 33(12):1943-52. PubMed ID: 22177370
[TBL] [Abstract][Full Text] [Related]
6. Phytotherapy of benign prostatic hyperplasia. A minireview.
Pagano E; Laudato M; Griffo M; Capasso R
Phytother Res; 2014 Jul; 28(7):949-55. PubMed ID: 25165780
[TBL] [Abstract][Full Text] [Related]
7. The effects of combination therapy with dutasteride and tamsulosin on clinical outcomes in men with symptomatic benign prostatic hyperplasia: 4-year results from the CombAT study.
Roehrborn CG; Siami P; Barkin J; Damião R; Major-Walker K; Nandy I; Morrill BB; Gagnier RP; Montorsi F;
Eur Urol; 2010 Jan; 57(1):123-31. PubMed ID: 19825505
[TBL] [Abstract][Full Text] [Related]
8. The prostaglandin pathway is activated in patients who fail medical therapy for benign prostatic hyperplasia with lower urinary tract symptoms.
Jin R; Strand DW; Forbes CM; Case T; Cates JMM; Liu Q; Ramirez-Solano M; Milne GL; Sanchez S; Wang ZY; Bjorling DE; Miller NL; Matusik RJ
Prostate; 2021 Sep; 81(13):944-955. PubMed ID: 34288015
[TBL] [Abstract][Full Text] [Related]
9. Combination of Ligustri Lucidi Fructus with Ecliptae Herba and their phytoestrogen or phytoandrogen like active pharmaceutical ingredients alleviate oestrogen/testosterone-induced benign prostatic hyperplasia through regulating steroid 5-α-reductase.
Tao R; Liu E; Zhao X; Han L; Yu B; Mao H; Yang W; Gao X
Phytomedicine; 2022 Jul; 102():154169. PubMed ID: 35636178
[TBL] [Abstract][Full Text] [Related]
10. The influence of baseline parameters on changes in international prostate symptom score with dutasteride, tamsulosin, and combination therapy among men with symptomatic benign prostatic hyperplasia and an enlarged prostate: 2-year data from the CombAT study.
Roehrborn CG; Siami P; Barkin J; Damião R; Becher E; Miñana B; Mirone V; Castro R; Wilson T; Montorsi F;
Eur Urol; 2009 Feb; 55(2):461-71. PubMed ID: 19013011
[TBL] [Abstract][Full Text] [Related]
11. [The use of ProstaDoz in patients with benign prostatic hyperplasia and coexistent high-grade prostatic intraepithelial neoplasia].
Antonov AG; Gordeev VV; Fedorchuk SB; Laptev DO
Urologiia; 2017 Oct; (5):58-62. PubMed ID: 29135144
[TBL] [Abstract][Full Text] [Related]
12. The effect of vitamin D supplementation on the progression of benign prostatic hyperplasia: A randomized controlled trial.
Zendehdel A; Ansari M; Khatami F; Mansoursamaei S; Dialameh H
Clin Nutr; 2021 May; 40(5):3325-3331. PubMed ID: 33213976
[TBL] [Abstract][Full Text] [Related]
13. Clinical outcomes after combined therapy with dutasteride plus tamsulosin or either monotherapy in men with benign prostatic hyperplasia (BPH) by baseline characteristics: 4-year results from the randomized, double-blind Combination of Avodart and Tamsulosin (CombAT) trial.
Roehrborn CG; Barkin J; Siami P; Tubaro A; Wilson TH; Morrill BB; Gagnier RP
BJU Int; 2011 Mar; 107(6):946-54. PubMed ID: 21332630
[TBL] [Abstract][Full Text] [Related]
14. What patients take without telling you: holistic approach for BPH.
Capodice JL; Katz AE
World J Urol; 2006 Sep; 24(4):378-82. PubMed ID: 16738853
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive patient evaluation for benign prostatic hyperplasia.
Jepsen JV; Bruskewitz RC
Urology; 1998 Apr; 51(4A Suppl):13-8. PubMed ID: 9586591
[TBL] [Abstract][Full Text] [Related]
16. Vitamin D and benign prostatic hyperplasia -- a review.
Espinosa G; Esposito R; Kazzazi A; Djavan B
Can J Urol; 2013 Aug; 20(4):6820-5. PubMed ID: 23930605
[TBL] [Abstract][Full Text] [Related]
17. Terazosin. A pharmacoeconomic evaluation of its use in benign prostatic hyperplasia.
Plosker GL; Goa KL
Pharmacoeconomics; 1997 Feb; 11(2):184-97. PubMed ID: 10165827
[TBL] [Abstract][Full Text] [Related]
18. Phytotherapeutic Agents for Benign Prostatic Hyperplasia: An Overview.
Sharma M; Chadha R; Dhingra N
Mini Rev Med Chem; 2017; 17(14):1346-1363. PubMed ID: 27337973
[TBL] [Abstract][Full Text] [Related]
19. Microwave thermotherapy for benign prostatic hyperplasia.
Hoffman RM; Monga M; Elliott SP; Macdonald R; Langsjoen J; Tacklind J; Wilt TJ
Cochrane Database Syst Rev; 2012 Sep; (9):CD004135. PubMed ID: 22972068
[TBL] [Abstract][Full Text] [Related]
20. A two-week, double-blind, placebo-controlled trial of Viola odorata, Echium amoenum and Physalis alkekengi mixture in symptomatic benign prostate hyperplasia (BPH) men.
Beiraghdar F; Einollahi B; Ghadyani A; Panahi Y; Hadjiakhoondi A; Vazirian M; Salarytabar A; Darvishi B
Pharm Biol; 2017 Dec; 55(1):1800-1805. PubMed ID: 28532232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
